Dendritic cell-based immunotherapy
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Dendritic cell-based immunotherapy, covering 2014-02-27 to 2025-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma [Phase 3]